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Abstract
Tick-borne relapsing fever (TBRF) is a potentially serious spirochetal infection caused by certain 
species of Borrelia and acquired through the bite of Ornithodoros ticks. In 2017, Austin Public 
Health, Austin, TX, identified five cases of febrile illness among employees who worked in caves. 
A cross-sectional serosurvey and interview were conducted for 44 employees at eight 
organizations that conduct cave-related work. Antibodies against TBRF-causing Borrelia were 
detected in the serum of five participants, four of whom reported recent illness. Seropositive 
employees entered significantly more caves (Median 25 [SD: 15] versus Median 4 [SD: 16], p = 
0.04) than seronegative employees. Six caves were entered more frequently by seropositive 
employees posing a potentially high risk. Several of these caves were in public use areas and were 
opened for tours. Education of area healthcare providers about TBRF and prevention 
recommendations for cavers and the public are advised.
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1 | INTRODUCTION
Tick-borne relapsing fever (TBRF) in humans follows infection with one of several Borrelia 
bacteria species. These bacteria can be trans-mitted rapidly to humans through the bite of 
Ornithodoros tick species. Ornithodoros ticks feed quickly and then detach and scatter; 
therefore, a victim might be unaware of the tick bite (Boyle, Wilder, Lawrence, & Lopez, 
2014). TBRF is characterized by episodes of fever, headache, myalgia, arthralgia and chills 
(Dworkin, Schwan, Anderson, & Borchardt, 2008). The initial fever will last approximately 
3 days, followed by 7 days without fever, followed by another 3 days of fever. Without 
antibiotic treatment, this process can repeat several times (Davis, Vincent, & Lynch, 2002; 
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Dworkin et al., 2008). In the United States, most TBRF cases are attributed to infection with 
Borrelia hermsii with patients commonly exposed in mountainous areas of western states, 
often following stays in seasonally used cabins (Dworkin, Shoemaker, Fritz, Dowell, & 
Anderson, 2002). A total of 504 TBRF cases were reported from twelve western states 
during 1990–2011; 18 of these were thought to have acquired their infection in Texas 
(Forrester, Kjemtrup, et al., 2015).
In Texas, Ornithodoros turicata transmits the TBRF causative agent, Borrelia turicatae 
(Davis, 1943; Donaldson et al., 2016; Rawlings, 1995). The B. turicatae lifecycle is 
maintained in this region by small and medium-sized animal hosts (Armstrong et al., 2018). 
Since 1930, human cases of TBRF in TX have occurred sporadically with activity in caves 
suggested as a risk factor (Dworkin et al., 2008; Forrester, Kjemtrup, et al., 2015; Rawlings, 
1995; Weller & Graham, 1930; Wilder et al., 2015). Weller and Graham (1930) described 
inspection of a cave outside of Austin, TX, in which “the floor was alive with ticks.” Other 
specific risk factors for TBRF in Texas have not been described.
In 2017, Austin Public Health (TX) identified an increase in reports of TBRF-like illness. In 
February, 11 people became ill after attending a workshop near Austin (Bissett et al., 2018). 
Attendees spent time in wooded areas and near wildlife, but none reported entering a cave. 
Blood samples from four patients were tested, and all had evidence of Borrelia infection, 
however, not specific for relapsing fever agents. In June and July, five people became ill after 
entering Austin area caves. Serum from three of the five was tested at CDC in Fort Collins, 
and two had antibodies to relapsing fever group borreliae.
Austin is located in Travis County and adjacent to Hays and Williamson Counties. The three 
counties encompass 2,791 square miles in southern central Texas (United States Census 
Bureau, 2010). Within these three counties, there are 1,338 documented caves, of the 5,600 
in Texas (Texas Speleological Society, 2016). Near Austin, a number of organizations 
employ people who enter caves or assess karst features for various occupation-related duties. 
State and local government organizations employ park rangers, biologists, surveyors, 
mammalogists, geologists, environmental conservationists and natural resource specialists. 
Private consulting companies employ people with similar titles and most often focus on 
performing karst surveys. Occupational cavers usually enter multiple caves in their duty area 
during all seasons and can spend hours in each cave.
For this investigation, Austin Public health worked with CDC to: (a) determine the 
frequency, duration and types of cave exposures among occupational cavers; (b) document 
the frequency of seropositivity for TBRF, occurrence of illness consistent with TBRF, and 
the clinical spectrum of illnesses experienced by occupational cavers; and (c) identify any 
differences in exposure, risk factors, or preventive strategies between seronegative and 
seropositive occupational cavers.
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2 | METHODS
2.1 | Inclusion criteria of organizations and employees
A local recreational caving group was consulted prior to the investigation. They provided 
information on government and private organizations in Hays, Travis and Williamson 
counties, TX, that employed at least one person who entered caves for their job. In addition, 
they identified a list of caves that are open to the public and/or perceived to be caves of risk 
for TBRF. Caves of risk for TBRF included ones where the tick vector had been previously 
seen or ones that people entered and then became ill a few days later. Organizations were 
contacted, and employees were invited to participate. All identified government 
organizations in the inclusion area of Travis, Williamson and Hays counties that employed at 
least one occupational caver participated. Of the ten identified private organizations, four 
agreed to participate. In total, eight government and private organizations participated and 
46 employees were enrolled. A point of contact for each organization received an email 1 
week prior to the study with information describing the purpose and logistics of the 
investigation.
2.2 | Data collection
We developed a questionnaire to collect demographic information, employment history, cave 
exposure, work-related activities in caves, use of protective measures in caves, and illness 
history. Participating employees who provided informed consent were interviewed in person 
during October 9 to 13, 2017. To capture cave exposure, employees were asked to name and 
rank their top 10 most frequently entered caves in the past 12 months. We asked about the 
duration of time (in hours) that employees spent in their top 10 most frequently visited 
caves.
2.3 | Serological testing
Serum samples were collected from participants at the time of interview. The CDC 
laboratory in Fort Collins, CO performed serology on the samples using two-tier testing 
(enzyme immunoassay and Western immunoblot) in which antibody reactivity to B. hermsii 
antigens was assessed (Fritz et al., 2004; Trevejo et al., 1998). Samples having positive 
results for both assays were interpreted as evidence of previous infection. TBRF serologic 
tests at CDC utilize B. hermsii antigen since the majority of cases in the United States are 
caused by B. hermsii, and it has been shown that TBRF caused by B. turicatae is detectable 
by the current tests (Christensen et al., 2017).
2.4 | PCR and DNA sequencing
To confirm that utilizing B. hermsii reagents to screen for antibodies to B. turicatae was 
appropriate, DNA sequencing was performed on a 627-bp fragment of the glpQ gene PCR-
amplified from cultures of two patients in the study that were previously diagnosed with 
TBRF. DNA was extracted from 200 μl of EDTA-treated whole blood from each patient and 
100 μl of the cultured spirochetes using a QIACube (Qiagen) with a QIAamp DNA Mini kit 
utilizing the blood and body fluid protocol in a final elution of 100 μl. PCR targeting the 
Borrelia relapsing fever group glpQ gene was performed. PCR primer sequences (5′–3′) 
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were as follows: RFglpQ-F GGAGCTGACTACCTAGAAC and RFglpQ-R 
GGGTATCCAAGGTCCAATTCC. Reactions were made with illustra puReTaq Ready-To-
Go PCR Beads (GE Healthcare) and contained 400 nM each primer, 2 μl DNA and nuclease-
free water to a final volume of 25 μl. PCR controls consisted of a DNA extraction buffer 
negative control (PBS), a PCR negative control (molecular grade H2O) and a PCR positive 
control (B. hermsii DNA). PCR was performed using a MJ Mini Thermal Cycler (Bio-Rad). 
Cycling conditions were 94°C for 3 min, and 30 cycles of 94°C for 1 min, 55°C for 1 min, 
72°C for 1 min, followed by 72°C for 10 min. PCR amplicon sizes (expected size of 627 bp) 
were verified using E-Gel 2% aga-rose gels (Invitrogen). For sequencing of PCR products, 
amplicons were purified using the QIAquick PCR purification kit (Qiagen) and quantified 
with a Nanodrop 8000 (ThermoFisher). Each amplicon was sequenced 4x each direction 
with the glpQ PCR primers and BigDye Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems). Reaction conditions included 8 μl of reaction mix, 0.33 nM PCR primer, 10 ng 
amplicon and nuclease-free water to 20 μl. Sequencing reactions were performed on the MJ 
Mini at 96°C for 1 min and 25 cycles of 96°C for 10 s, 50°C for 5 s, and 60°C for 4 min. 
Reactions were purified with Centri-Sep spin columns (Applied Biosystems) and sequencing 
performed on a 3130xl Genetic Analyzer (Applied Biosystems). Sequence files were 
assembled with Seq Builder Pro (DNAStar), and contig files with trimmed ends (556 bp) 
were aligned to Borrelia sequences from GenBank using MegAlign (DNAStar). Clustal W 
slow-accurate pairwise alignment was performed to determine sequence identity.
2.5 | Statistical analysis
Data were entered into an Epi Info 7.1.5.0 database. Statistical analyses were conducted 
using SAS 9.4. For this analysis, employees who tested seropositive were compared to the 
referent group of seronegative employees. Odds ratios were generated for dichotomous 
variables, and the Fisher’s exact test was used to compare frequencies between seropositive 
and seronegative employees. The Wilcoxon rank-sum test was used to evaluate associations 
between seropositive and seronegative employees with p values <0.05 considered 
statistically significant. This investigation underwent ethical and regulatory review following 
standardized processes at the National Center for Emerging and Zoonotic Infectious 
Diseases, and in accordance with CDC policy. It was determined to be a non-research public 
health response, and therefore was not subject to formal IRB review requirements, although 
informed consent was obtained from all participants, in keeping with accepted ethical 
standards.
3 | RESULTS
Questionnaires were completed, and serum samples were collected from 44 employees; 
median age of respondents was 40 years (range: 21–73), and 27/44 (61%) were male (Table 
1). Nearly all (42/44; 95%) employees entered caves for their occupation at some point in 
the past. Many employees (33/44; 75%) entered caves in Hays, Travis or Williamson 
Counties in the past 12 months (Table 1). Overall, employees reported entering a median of 
4.5 (range: 0–50) different caves in the past 12 months (Table 1). Employees spent an 
average of 2.2 (range: 0.1–12) hours in their 10 most frequently entered caves. More than 
half of employees (26/44; 59%) reported seeing small or medium-sized animals in the caves. 
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The most common animal types seen were porcupines (21), raccoons (15) and mice (13). 
Among all employees, five of 44 were identified in the serosurvey with two-tier positive 
reactivity to B. hermsii antigens on EIA and immunoblot (5/44; 11%). Two of the five 
seropositive respondents were previously diagnosed with TBRF, with B. turicatae culture 
confirmation performed at CDC 3 months prior to this investigation. These employees were 
interviewed and gave a second blood sample. Comparison of glpQ sequences from both the 
blood samples and the recovered cultures with publicly available relapsing fever group 
Borrelia species in NCBI demonstrated they shared 100% identity to B. turicatae (Table 2). 
Both confirmed cases attributed to B. turicatae infection were seropositive using B. hermsii 
antigen, suggesting that B. hermsii reagents can be used to screen for antibodies to B. 
turicatae.
3.1 | Cave exposure patterns among seropositive employees
Among the five seropositive employees were three biologists and two park rangers. All five 
employees reported cave exposure in the inclusion area within the previous 12 months. 
Seropositive employees entered significantly more caves than seronegative employees 
(Median 25 vs. Median 4; p = 0.04; Table 3). There were no other significant differences in 
exposures among the seropositive and seronegative employees. In addition to entering Texas 
caves, one person who was seropositive reported entering caves in New Mexico and another 
seropositive person reported entering caves in Germany and Mexico. Of all caves entered by 
employees, six were identified as being significantly more visited by seropositive than 
seronegative employees (Figure 1).
There was no difference between seronegative and seropositive employees with respect to 
any protective measures (Table 4). Among employees that did not use permethrin, seventeen 
said the primary reason was that it was harmful to the cave ecosystem (17/37; 45.9%; Table 
5). Of all employees that did not use repellents, ten said the primary reason was that it was 
harmful to the cave ecosystem (10/22; 45%; Table 5).
3.2 | Illness patterns among seropositive employees
Of the five seropositive employees, four reported illness, during the past year, consistent 
with TBRF for which they sought medical care. Among these, three were diagnosed with 
TBRF by a healthcare provider. One of the four seropositive employees who sought medical 
care was possibly misdiagnosed with typhoid fever in the previous 12 months. The fifth 
person who was seropositive reported no history of illness consistent with TBRF.
Among the four seropositive that reported TBRF-like illness, all reported experiencing fever, 
with a temperature range of 103.5–105 F. Only one person experienced a relapsing fever 
consisting of a single relapse, lasting 6 days, with 5 days between fevers. In addition, all felt 
fatigue and experienced sweating, chills and a loss of appetite. Three out of four employees 
reported at least one of the following symptoms: vivid dreams, hallucinations, sensitivity to 
light, aching, headache, confusion, tingling or weakness of extremities, vomiting and 
nausea. Half of the employees who reported illness said they had a rash (Table 6); only one 
person each reported having irregular heart rate, neck pain or sore throat. All four of the 
seropositive employees with symptoms were treated with doxycy-cline. Three of the four 
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seropositive employees who were treated reported experiencing additional symptoms, 
including worsening fever, lethargy, dizziness and others, after starting treatment. These 
symptoms were consistent with a Jarisch–Herxheimer reaction.
4 | DISCUSSION
This investigation provides additional information in support of the association between 
TBRF and cave exposure. Of the 44 enrolled, five persons had evidence of infection with 
relapsing fever Borrelia, all of which entered caves in the previous 12 months. Entering a 
greater number of caves was significantly associated with seropositivity. By entering more 
caves, employees could have increased opportunity for exposure to the vector O. turicata. 
Providing cave tours was a marginally significant finding, and it is possible that providing 
cave tours is a surrogate for frequency of cave visits. If employees were repeatedly providing 
tours in caves and these caves had infected O. turicata ticks, then this could increase the 
employee’s opportunity for exposure and risk of infection.
Seropositive employees entered six specific caves more frequently than seronegative 
employees. Five of the six caves are located in southwest Austin, and three were previously 
identified by the local caving group as potentially high-risk caves. Interestingly, the location 
of the workshop where 11 people became ill with febrile illness in early 2017 is located 
within ten miles of the five suspect Austin area caves. In response to the findings of this 
investigation, the City of Austin performed tick sampling on three separate occasions in 
three of the six caves and found no soft ticks. They chose these three caves, from the six 
identified as potentially risky, because they are primarily used for educational tours. The 
lack of soft-bodied ticks identified in these caves is reassuring, but continued monitoring for 
Borrelia-infected ticks is essential to evaluate the identified caves in this area of Austin to 
determine the risk assessment, compared to less frequently visited caves.
There is no information on the rate of subclinical infection with B. turicatae in the literature. 
One seropositive individual did not report symptoms of TBRF or ever being diagnosed with 
TBRF. It is possible that this person experienced mild symptoms that they associated with 
another type of illness or that they were misdiagnosed. In addition, because serological 
testing is usually performed during or shortly after acute illness, there is limited information 
on how long a person will have serologic reactivity for TBRF utilizing the recommended 
two-tier testing. The person who reported no symptoms may have experienced illness >12 
months ago, which was outside of the timeframe of this investigation. The two employees 
who were diagnosed with TBRF 3 months prior to this investigation had positive serology 
results in this study. This was a meaningful finding and provided evidence that serology can 
be a useful diagnostic tool several months post-infection.
The seropositive individual with no clinical signs and the employee diagnosed with a 
different infectious disease in this investigation suggest that there could be other 
unrecognized or misdiagnosed cases of TBRF in Texas. It is possible that a background rate 
of infection exists among people living in Texas who have not been tested or diagnosed with 
TBRF. In 2016, Texas reported 71 cases of Lyme disease. Lyme disease is not endemic to 
Texas, and while many of these cases likely involved travel to high-incidence areas, it is also 
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possible that some of these were unrecognized cases of TBRF (Forrester, Brett, et al., 2015). 
Previous reports indicate cross-reacting antibodies to Borrelia burgdorferi among people and 
animals confirmed with Borrelia-causing relapsing fever (Esteve-Gasent, Snell, Adetunji, & 
Piccione, 2017; Rath, Rogler, Schonberg, Pohle, & Fehrenbach, 1992). Immunoblot results 
have shown reactivity to specific antigens shared by both pathogens (Rath et al., 1992). In 
areas where Lyme disease is not endemic and the patient has not travelled to a high-
incidence area, serologic results for Lyme borreliosis should be interpreted cautiously 
(Forrester, Brett, et al., 2015).
In this population, signs and symptoms were consistent with previous case reports of 
relapsing fever (including fever, chills, headache, sensitivity to light, confusion, myalgia, 
arthralgia, vomiting and nausea) (Dworkin et al., 2008). In addition, three employees 
reported having vivid dreams, hallucinations and tingling or weakness of extremities. These 
symptoms have not been reported previously among patients infected with B. hermsii, and 
only infrequently among patients with B. turicatae (Rawlings, 1995). This is supportive of 
the idea that B. turicatae is more neurotropic than other relapsing fever Borrelia (Cadavid & 
Barbour, 1998; Sethi, Sondey, Bai, Kim, & Cadavid, 2006). It is not surprising that three of 
the four employees who were ill did not experience relapsing fevers as a result of the 
promptness of initiating treatment with doxycycline after initial symptoms. Three employees 
experienced ongoing or additional symptoms after starting treatment with doxycycline 
which could be consistent with a Jarisch–Herxheimer reaction. This would be consistent 
with TBRF literature, where over 50% of cases experience a Jarisch–Herxheimer reaction 
upon initiation of antibiotic treatment (Dworkin et al., 2008).
There were several limitations in this investigation. The organizations that were invited to 
participate were identified by word of mouth from members of the caving community near 
Austin, TX. It is possible that some organizations were not identified or invited to 
participate. It is also possible that there are differences among participating organizations or 
among employees that chose to participate as compared to the ones that did not participate. 
In addition, we recruited people that had cave exposure in the previous 12 months, so there 
was no control group without cave exposure for comparison. Another consideration is that in 
the south and southwest states where B. turicatae occurs, infection is not always associated 
with cave exposure. TBRF can also be acquired by entering other environments inhabited by 
infected ticks such as crawl spaces and underneath houses. So, while we believe the five 
seropositive employees in this investigation likely were exposed to the relapsing fever 
bacteria by a tick bite in caves, we cannot rule out other potential exposure locations. Lastly, 
a diagnostic limitation is that serology cannot differentiate between species of relapsing 
fever Borrelia, so we cannot definitively know that all of the seropositives were due to B. 
turicatae. Since relapsing fever Borrelia are geographically specific, with B. turicatae 
predominantly identified from Texas cases, and since speciation was performed on two of 
the five seropositive specimens, we believe it is likely that seropositivity was due to B. 
turicatae infection.
In this investigation, there were no significant differences with respect to any protective 
measures. The cave environment also presents challenges to making prevention 
recommendations. Employees emphasized the need to be mobile throughout the caves 
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without clothing or personal protective equipment catching on the cave wall or floor, or 
impeding movement. Some of the employees included in this investigation enter caves to 
conduct animal and in-vertebrate surveys. These employees play a role in preserving and 
protecting the caves’ ecosystems; thus, removing host animals that ticks parasitize is not a 
viable option to preventing human illnesses. In addition, although use of chemical acaricides 
is the most common recommendation for tick control, studies have suggested that chemical 
acaricides would cause a disruption to the cave ecosystem (Diaz-Martin, Manzano-Roman, 
Obolo-Mvoulouga, Oleaga, & Perez-Sanchez, 2015). Similarly, many employees believed 
that using permethrin on their clothes or repellents on their skin would be harmful to the 
cave ecosystem. Small and medium-sized animals are known hosts in the TBRF lifecycle. 
Employees who work in caves should be aware that the presence of animals or their nests 
may indicate an increased risk for the Ornithodoros tick.
As an uncommon disease with a range of clinical symptoms, TBRF can be difficult to 
identify (Christensen et al., 2017). To improve healthcare provider recognition and 
knowledge, key TBRF information was summarized and published in a Texas medical 
society journal (Campbell, Huang, Kirkpatrick, Klioueva, & Taylor, 2018). Providing 
education to cavers in Texas could similarly allow for awareness of tick presence and 
recognition of disease. Cavers can serve as their own health advocates and discuss treatment 
options with their healthcare provider. Additional studies on the incidence of TBRF in Texas 
and ecology of the vector O. turicata are warranted.
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Impacts
• The findings of this investigation support the hypoth-esized association 
between tick-borne relapsing fever (TBRF) and cave exposure. Occupational 
cavers who entered a greater number of caves were significantly more likely 
to have serologic evidence of past exposure to TBRF bacteria.
• Certain caves appeared to be riskier than others for exposure to TBRF 
bacteria. Six caves were found to be higher risk in this investigation, five of 
which are located in southwest Austin. Monitoring this part of Austin through 
tick sampling and additional ecologic assessment is needed.
• The cave environment presents challenges to standard tick bite prevention 
practices because of its sensitive ecosystem that could be harmed by chemical 
acaricides. People entering caves should be aware of TBRF and utilize 
alternative protective measures, such as wearing long clothing.
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Figure 1. 
Location of caves, within Austin city limits, most frequently visited by employees 
seropositive (n = 5) for antibodies against TBRF‐causing Borrelia–Austin, Texas, 2017. See 
figure attached. One cave found to be frequently visited by seropositive employees is not 
shown on this map due to its location outside of the defined investigation area
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TABLE 1
Demographic characteristics of employees surveyed from eight organizations that employ occupational cavers 
(n = 44)—Austin, Texas, 2017
Characteristic No.
Total 44
Male, No. (%) 27 (61)
Age in years, median (range) 40 (21–73)
Employer, No. (%)
 City/County 27 (61)
 State of Texas 2 (5)
 Private company 15 (34)
Entered caves for occupation 42 (95)
Years entered caves for occupation, median (range) 4 (1–38)
Entered caves for recreation (%) 18 (41)
Years entered caves for recreation, median (range) 18 (1–47)
Entered caves in Hays, Travis, or Williamson counties in past 12 months (%) 33 (75)
Number of caves entered in the past 12 months, median (range) 4.5 (0–50)
Time spent (hours) in 10 most frequently entered caves, median (range) 2.2 (0.1–12)
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TABLE 5
Primary reason for not using permethrin (n = 37) or repellents (n = 22) among employees—Austin, Texas, 
2017
Reason for not using
Permethrin (n = 37) Repellents (n = 22)
No. (%) No. (%)
Harmful to cave ecosystem 17 (45.9) 10 (45.5)
Don’t want to 8 (21.6) 5 (22.7)
No risk of ticks 8 (21.6) 6 (27.3)
Don’t know what it is 3(8.1) 0
Does not work well 1 (2.7) 1 (4.5)
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TABLE 6
Clinical signs among employees seropositive (n = 5) for antibodies against TBRF-causing Borrelia—Austin, 
Texas, 2017
Patient 1 2 3 4 5
Fever X X X X
Chills X X X X
Loss of appetite X X X X
Fatigue X X X X
Sweats X X X X
Aching X X X
Confusion X X X
Hallucinations X X X
Headache X X X
Nausea X X X
Sensitivity to light X X X
Tingling/weakness of extremities X X X
Vivid dreams X X x
Vomiting X X x
Rash X X
Zoonoses Public Health. Author manuscript; available in PMC 2020 February 26.
